Legacy Financial Independent Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Sell
3,251
-598
-16% -$611K 1.83% 19
2026
Q1
$3.54M Buy
+3,849
New +$3.9M 1.84% 22

Other funds holding LLY

Legacy Financial Independent Advisors's LLY Position: Q2 2026 in Review

Legacy Financial Independent Advisors reduced its Eli Lilly (LLY) stake by 16% in Q2 2026, selling an estimated $611K and leaving 3,251 shares worth $3.9M. The position accounts for 1.83% of the portfolio, ranked #19.

Legacy Financial Independent Advisors first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,596 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Financial Independent Advisors held 3,251 shares of Eli Lilly worth $3.9M as of Q2 2026.
  • Legacy Financial Independent Advisors sold 598 Eli Lilly shares in Q2 2026, an estimated $611K.
  • Eli Lilly made up 1.83% of Legacy Financial Independent Advisors's portfolio in Q2 2026, its #19 holding.
  • Legacy Financial Independent Advisors first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,596 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Financial Independent Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.